Cas:620-67-7 TRIHEPTANOIN manufacturer & supplier

Chemical Name:TRIHEPTANOIN

CAS.NO:620-67-7

Synonyms:Triheptanoin;Glycerol-1,2,3-triheptanoate;TRIHEPTANION;trioenanthoin;Propane-1,2,3-triyl triheptanoate;trienanthoin;propane-1,2,3-triyl trisheptanoate;1,2,3-Propanetriyl triheptanoate;glyceryl triheptanoate;glycerol trienanthate;1,2,3-tris-heptanoyloxy-propane;glyceroltriheptanoate;triheptylin;tri-heptanoi;1,2,3-Tris-heptanoyloxy-propan;Heptanoic acid, 1,2,3-propanetriyl ester;triheptanoicglyceride;TRIOENANTHIN

Molecular Formula:C₂₄H₄₄O₆

Molecular Weight:428.603

HS Code:2915900090

Physical and Chemical Properties:

Melting point:N/A

Boiling point:470.0±12.0 °C at 760 mmHg

Density:1.0±0.1 g/cm3

Index of Refraction:1.457

PSA:78.90000

Exact Mass:428.313782

LogP:7.73

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like Triheptanoin chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,TRIOENANTHIN physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,tri-heptanoi Use and application,TRIHEPTANION technical grade,usp/ep/jp grade.

Related News: The survival benefit is “unprecedented” for an aging myeloma population, almost all of whom were 65 years of age or older, said Craig Tendler, M.D., vice president of oncology clinical development and global medical affairs at J&J’s Janssen unit, during an interview. TRIHEPTANOIN manufacturer The survival benefit is “unprecedented” for an aging myeloma population, almost all of whom were 65 years of age or older, said Craig Tendler, M.D., vice president of oncology clinical development and global medical affairs at J&J’s Janssen unit, during an interview. TRIHEPTANOIN supplier In August, the Company announced that the U.S. Patent and Trademark Office issued U.S. Patent No. 10,370,452 covering compositions and uses of effector T cells expressing a CAR, where such T cells are derived from a pluripotent stem cell, including an iPSC. TRIHEPTANOIN vendor In August, the Company announced that the U.S. Patent and Trademark Office issued U.S. Patent No. 10,370,452 covering compositions and uses of effector T cells expressing a CAR, where such T cells are derived from a pluripotent stem cell, including an iPSC. TRIHEPTANOIN factory The survival benefit is “unprecedented” for an aging myeloma population, almost all of whom were 65 years of age or older, said Craig Tendler, M.D., vice president of oncology clinical development and global medical affairs at J&J’s Janssen unit, during an interview.